Back to Top Skip to main content

Camp Pendleton Marines and civilians donate blood to save others

Two people in masks giving blood U.S. Navy corpsmen prep volunteers to donate blood and be tested for coronavirus antibodies outside of the Center for Naval Aviation Technical Training Marine Detachment on Marine Corps Base Camp Pendleton, California in August. The event was hosted by the Armed Services Blood Program. (U.S. Marine Corps photo by Lance Cpl. Drake Nickels)

Recommended Content:

Coronavirus | Convalescent Plasma Collection Program

The COVID-19 Convalescent Plasma (CCP) Collection Program is a Department of Defense effort to obtain 10,000 units CCP with emphasis on blood donations by members of the military community who have recovered from the disease. CCP will be given to critically ill patients, and to support the development of an effective treatment against the disease. Potential donors should visit the Armed Services Blood Program website at: https://www.militaryblood.dod.mil/Donors/COVID-19andBloodDonation.aspx - to find a complete list of available collection centers.

Earlier this month, the Armed Services Blood Program hosted a volunteer blood drive and coronavirus antibody test at the Center for Naval Aviation Technical Training Marine Detachment on Marine Corps Base Camp Pendleton, California.

“Today is a very special blood drive,” said Cesar Fontanilla, a blood donor recruiter with the ASBP. “This blood drive could help collect plasma from recovered COVID-19 patients.”

Once screened, each donor gave one pint of blood, which could save up to three lives.

The ASBP takes the blood and tests it before accepting the donation for use. As part of the process, all donations are now being tested for COVID-19 antibodies. The antibodies would be present in the blood if the donors have been exposed to COVID-19 and have since recovered. The ASBP test for the COVID-19 antibodies along with other illnesses that they typically test for, like gonorrhea and HIV.

After the blood is processed and has been screened for any disqualifying illnesses and COVID-19 antibodies, the ASBP will notify the donor with their results. If the antibodies are present, the ASBP will ask the donors to optionally donate their blood plasma.

“We aren't testing to see if you have COVID-19, rather we’re testing to see if you had it,” said Navy Petty Officer 2nd Class Jayden Ryan, petty officer in charge of the Military Blood Program, Naval Medical Readiness and Training Command San Diego. “Later we can use the antibodies from the donors that had COVID-19 to treat someone who may have a worse case.”

The ASBP donation center only accepts donations for military members and their dependents.

To schedule a center to come to your unit contact your local blood donor recruiter by visiting Militarydonor.com.

For more info on donating, visit www.militaryblood.dod.mil.

You also may be interested in...

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

DHA-PI 6205.01: Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (n), establishes the Defense Health Agency's (DHA's) procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits.

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

DHA-IPM 20-004: Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

This Defense Health Agency (DHA) Interim Procedures Memorandum (IPM), based on the authority of References (a) through (d), and in accordance with the guidance cited in References (e) through (aa), establishes the DHA’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the COVID-19 Vaccination Program. This DHA-IPM applies to DHA, DHA Components (activities under the authority direction, and control of the DHA), Military Departments (MILDEP), and the United States Coast Guard (CG). This DHA-IPM cancels and replaces DHA-IPM 20-004, “Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation,” December 13, 2020.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

DHA-AI 3020-01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), based on the authority of References (a) through (b) and in accordance with the guidance of References (c) through (z3), establishes the Defense Health Agency's (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic. This DHA-AI also provides a preventive plan to monitor and assess for the appearance of new cases and implement those processes that will prevent them from impacting the workforce. The processes describe herein are intended to offer an actionable plan for the workforce to re-enter DHA Administrative Offices. See Appendix 1 for a summary of the DHA Administrative Office Reopening Plan. The plan uses the Force Health Protection Guidance and Health Protection Conditions (HPCON), in accordance with Reference (d), to ensure protection for the workforce, including the most vulnerable-to-serious complications from the virus while enabling DHA Administrative Offices to continue its mission. See Appendix 2 for the conceptual HPCON framework.

  • Identification #: 3020-01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DHA AI 3020.01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 (COVID-19) Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), establishes the Defense Health Agency’s (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic and in preparation for regression or resurgence in COVID-19 cases that could impact the workforce.

  • Identification #: DHA AI 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus
Showing results 1 - 10 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.